Maharashtra`s Food and Drug Administration (FDA) has issued a show-cause notice to a pharmaceutical company in Palghar for ...

At least 11 employees working at the FDA's Center for Devices and Radiological Health - which oversees medical device reviews ...

Jagsonpal Pharmaceuticals has received a warning from the USFDA for significant manufacturing lapses at its API plant in Rajasthan. The US regulator cites deviations from Good Manufacturing Practice, ...

Innoviva's shift to specialty therapeutics is backed by strong financials and a robust pipeline. Read why INVA stock presents ...

The current state of health services highlights crucial sectors facing disruptions and developments, from US foreign aid freezes affecting disease control supply chains, to the FDA's actions on new ...

WASHINGTON - The US Food and Drug Administration (FDA) is asking some of its recently fired scientists if they will come back ...

The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...

(Reuters) - The U.S. Food and Drug Administration is asking some of its recently fired scientists if they will come back to their jobs, including some employees reviewing Elon Musk's brain implant ...

Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, offering a new treatment option for cardiovascular protection. Sotagliflozin, a re ...

Esperion Therapeutics has two approved LDL-C lowering therapies, Nexletol and Nexlizet, but lacks a strong pipeline for future growth.

An off-label prescription drug has been shown to help children with autism gain the ability to speak. Leucovorin is used for cancer patients, but doctors are pushing for its approval for autism.